Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKY NETWORK TELEVISION LIMITED. Director's Dealing 2025

Aug 27, 2025

65806_rns_2025-08-28_0a4d9242-cd8f-43ed-9f49-08019edd6e89.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [76 x 24] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure: Director or senior manager giving disclosure Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Sky Network Television Limited 28 August 2025 30 May 2024 Philip Bowman Sky Network Television Limited N/A Director

Director or senior managergiving disclosure
Full name(s): PhilipBowman
Name of listed issuer: SkyNetwork Television Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Ordinary shares in Sky Network
Class of affected quoted financial products: Television Limited (NZX/ASX security
code: SKT)
Nature of the affected relevant interest(s): Registered holder and beneficial
owner
For that relevant interest-
Number held in class before acquisition or disposal: 750,000
Number held in class after acquisition or disposal: 800,000
Current registered holder(s): PhilipBowman
Registered holder(s)once transfers are registered: N/A
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: N/A
Class of underlyingfinancial products: N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financialproducts(if any): N/A
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expirydate of the derivative(if any): N/A
Theprice specified in the terms of the derivative(if any): N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products: N/A
_For that derivative,- _
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative: N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot readily be
converted into a cash value,describe the consideration:
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot readily be
converted into a cash value,describe the consideration:
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:
25 August 2025 26 August 2025
On-market acquisition of ordinary
shares
On-market acquisition of ordinary
shares
Unknown Unknown
$141,108.95 $15,964.20
44,932 5,068
No
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Whether relevant interests were acquired or disposed of duringa closedperiod: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:
N/A
Date of the prior written clearance (if any): N/A
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative: N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price's specified terms (if any): N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
N/A
For that derivative relevant interest,-
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
28 August 2025
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person: